Class information for:
Level 1: ESCITALOPRAM//VENLAFAXINE//MILNACIPRAN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3683 1932 38.1 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
154 3       PSYCHIATRY//ALEXITHYMIA//PSYCHIAT 62481
207 2             PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION 21074
3683 1                   ESCITALOPRAM//VENLAFAXINE//MILNACIPRAN 1932

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ESCITALOPRAM authKW 386121 6% 21% 117
2 VENLAFAXINE authKW 270214 6% 15% 117
3 MILNACIPRAN authKW 259515 3% 26% 62
4 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY journal 243029 9% 9% 168
5 DESVENLAFAXINE authKW 207633 2% 45% 29
6 SEVERE DEPRESSION authKW 197807 1% 48% 26
7 ANTIDEPRESSANTS authKW 133543 14% 3% 266
8 SERTRALINE authKW 129598 4% 10% 82
9 DULOXETINE authKW 97410 3% 10% 61
10 PAROXETINE authKW 96537 4% 7% 82

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Psychiatry 62375 64% 0% 1238
2 Pharmacology & Pharmacy 12330 47% 0% 904
3 Psychology, Clinical 3753 10% 0% 198
4 Clinical Neurology 2224 16% 0% 308
5 Psychology 875 5% 0% 99
6 Medicine, General & Internal 691 10% 0% 198
7 Health Policy & Services 671 3% 0% 64
8 Neurosciences 469 11% 0% 222
9 Health Care Sciences & Services 405 4% 0% 68
10 Primary Health Care 191 1% 0% 21

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INT HLTH ECON EPIDEMIOL 81272 0% 86% 6
2 COCHRANE ABORAT DEP S ANXIETY NEUROSIS RE 35556 0% 75% 3
3 COSTA PONENT TEACHING UNIT 31607 0% 100% 2
4 INLAND NW 31607 0% 100% 2
5 INSERMEA 512 31607 0% 100% 2
6 NERVOUS SYST DISORDERS THER EUT AREA 31607 0% 100% 2
7 INT CONSORTIUM MOOD PSYCHOT DISORDERS 28444 0% 60% 3
8 NEBRASKA MED 985580 28444 0% 60% 3
9 MEDICOPSYCHOL B 23702 0% 50% 3
10 ECON PRICING 21070 0% 67% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 243029 9% 9% 168
2 JOURNAL OF CLINICAL PSYCHIATRY 68298 9% 2% 175
3 HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 34331 3% 4% 61
4 PSYCHOPHARMAKOTHERAPIE 24876 1% 6% 28
5 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 23108 3% 2% 63
6 ACTA PSYCHIATRICA SCANDINAVICA 15823 4% 1% 78
7 JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY 12949 1% 5% 15
8 PSYCHOPHARMACOLOGY BULLETIN 12034 2% 2% 37
9 INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 11178 1% 3% 24
10 ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE 9338 2% 2% 37

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ESCITALOPRAM 386121 6% 21% 117 Search ESCITALOPRAM Search ESCITALOPRAM
2 VENLAFAXINE 270214 6% 15% 117 Search VENLAFAXINE Search VENLAFAXINE
3 MILNACIPRAN 259515 3% 26% 62 Search MILNACIPRAN Search MILNACIPRAN
4 DESVENLAFAXINE 207633 2% 45% 29 Search DESVENLAFAXINE Search DESVENLAFAXINE
5 SEVERE DEPRESSION 197807 1% 48% 26 Search SEVERE+DEPRESSION Search SEVERE+DEPRESSION
6 ANTIDEPRESSANTS 133543 14% 3% 266 Search ANTIDEPRESSANTS Search ANTIDEPRESSANTS
7 SERTRALINE 129598 4% 10% 82 Search SERTRALINE Search SERTRALINE
8 DULOXETINE 97410 3% 10% 61 Search DULOXETINE Search DULOXETINE
9 PAROXETINE 96537 4% 7% 82 Search PAROXETINE Search PAROXETINE
10 R CITALOPRAM 91942 0% 73% 8 Search R+CITALOPRAM Search R+CITALOPRAM

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ANDERSON, IM , (2000) SELECTIVE SEROTONIN REUPTAKE INHIBITORS VERSUS TRICYCLIC ANTIDEPRESSANTS: A META-ANALYSIS OF EFFICACY AND TOLERABILITY.JOURNAL OF AFFECTIVE DISORDERS. VOL. 58. ISSUE 1. P. 19 -36 107 88% 430
2 CIPRIANI, A , FURUKAWA, TA , SALANTI, G , GEDDES, JR , HIGGINS, JPT , CHURCHILL, R , WATANABE, N , NAKAGAWA, A , OMORI, IM , MCGUIRE, H , ET AL (2009) COMPARATIVE EFFICACY AND ACCEPTABILITY OF 12 NEW-GENERATION ANTIDEPRESSANTS: A MULTIPLE-TREATMENTS META-ANALYSIS.LANCET. VOL. 373. ISSUE 9665. P. 746 -758 65 62% 644
3 RUTHERFORD, BR , COOPER, TM , PERSAUD, A , BROWN, PJ , SNEED, JR , ROOSE, SP , (2013) LESS IS MORE IN ANTIDEPRESSANT CLINICAL TRIALS: A META-ANALYSIS OF THE EFFECT OF VISIT FREQUENCY ON TREATMENT RESPONSE AND DROPOUT.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 74. ISSUE 7. P. 703-715 83 73% 6
4 GARTLEHNER, G , GAYNES, BN , HANSEN, RA , THIEDA, P , DEVEAUGH-GEISS, A , KREBS, EE , MOORE, CG , MORGAN, L , LOHR, KN , (2008) COMPARATIVE BENEFITS AND HARMS OF SECOND-GENERATION ANTIDEPRESSANTS: BACKGROUND PAPER FOR THE AMERICAN COLLEGE OF PHYSICIANS.ANNALS OF INTERNAL MEDICINE. VOL. 149. ISSUE 10. P. 734 -U313 123 42% 114
5 ANDERSON, IM , TOMENSON, BM , (1995) TREATMENT DISCONTINUATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS COMPARED WITH TRICYCLIC ANTIDEPRESSANTS - A METAANALYSIS.BMJ-BRITISH MEDICAL JOURNAL. VOL. 310. ISSUE 6992. P. 1433 -1438 82 89% 236
6 ANDERSON, IM , TOMENSON, BM , (1994) THE EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN DEPRESSION - A METAANALYSIS OF STUDIES AGAINST TRICYCLIC ANTIDEPRESSANTS.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 8. ISSUE 4. P. 238 -249 83 84% 210
7 JAKUBOVSKI, E , VARIGONDA, AL , FREEMANTLE, N , TAYLOR, MJ , BLOCH, MH , (2016) SYSTEMATIC REVIEW AND META-ANALYSIS: DOSE-RESPONSE RELATIONSHIP OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN MAJOR DEPRESSIVE DISORDER.AMERICAN JOURNAL OF PSYCHIATRY. VOL. 173. ISSUE 2. P. 174 -183 37 74% 10
8 BRADLEY, AJ , LENOX-SMITH, AJ , (2013) DOES ADDING NORADRENALINE REUPTAKE INHIBITION TO SELECTIVE SEROTONIN REUPTAKE INHIBITION IMPROVE EFFICACY IN PATIENTS WITH DEPRESSION? A SYSTEMATIC REVIEW OF META-ANALYSES AND LARGE RANDOMISED PRAGMATIC TRIALS.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 27. ISSUE 8. P. 740 -758 57 78% 10
9 LEONARD, B , TAYLOR, D , (2010) ESCITALOPRAM-TRANSLATING MOLECULAR PROPERTIES INTO CLINICAL BENEFIT: REVIEWING THE EVIDENCE IN MAJOR DEPRESSION.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 24. ISSUE 8. P. 1143 -1152 66 73% 10
10 ECCLES, M , FREEMANTLE, N , MASON, J , (1999) NORTH OF ENGLAND EVIDENCE-BASED GUIDELINE DEVELOPMENT PROJECT: SUMMARY VERSION OF GUIDELINES FOR THE CHOICE OF ANTIDEPRESSANTS FOR DEPRESSION IN PRIMARY CARE.FAMILY PRACTICE. VOL. 16. ISSUE 2. P. 103 -111 79 81% 30

Classes with closest relation at Level 1


Rank Class id link
1 7414 TREATMENT RESISTANT DEPRESSION//RESISTANT DEPRESSION//LITHIUM AUGMENTATION
2 23948 MIRTAZAPINE//ORG 3770//MIRTAZAPINE ORG 3770
3 12254 NORFLUOXETINE//CITALOPRAM//FLUOXETINE
4 17446 ANTIDEPRESSANTS//ANTIDEPRESSANT ADHERENCE//ESTADES PRACT TUTELADES UNIT
5 26382 DULOXETINE//DULOXETINE HYDROCHLORIDE//GLOBAL PHARMACOKINET PHARMACODYNAM TRIAL SIMULAT
6 6752 CHRONIC DEPRESSION//DYSTHYMIA//DYSTHYMIC DISORDER
7 17931 ACTIVATION SYNDROME//FORENS TOXICOL FORENS GENET//N WALES PSYCHOL MED
8 19698 TRAZODONE//NEFAZODONE//ETOPERIDONE
9 32254 VORTIOXETINE//LU AA21004//BIS ARYL SULFANYLA MINE
10 15848 SDLP//CRITICAL FLICKER FUSION THRESHOLD//ON THE ROAD DRIVING

Go to start page